Retractable Technologies (NYSE:RVP) Shares Down 1.3% – Should You Sell?

Posted by ABMN Staff on Jan 28th, 2026

Shares of Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) dropped 1.3% during trading on Tuesday . The stock traded as low as $0.72 and last traded at $0.7202. Approximately 66,773 shares traded hands during mid-day trading, an increase of 39% from the average daily volume of 48,198 shares. The stock had previously closed at $0.73.

Retractable Technologies Stock Down 1.3%

The stock’s fifty day simple moving average is $0.79 and its 200-day simple moving average is $0.81. The stock has a market cap of $21.56 million, a P/E ratio of -1.33 and a beta of 1.15. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57.

Institutional Trading of Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. Susquehanna International Group LLP lifted its stake in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) by 135.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 54,546 shares of the company’s stock after purchasing an additional 31,362 shares during the quarter. Susquehanna International Group LLP owned 0.18% of Retractable Technologies worth $46,000 as of its most recent SEC filing. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc is a U.S.-based medical device company specializing in the design, development and manufacture of safety-engineered injection technologies aimed at reducing needlestick injuries. Headquartered in Little Elm, Texas, Retractable Technologies offers proprietary needle retraction systems that automatically withdraw the needle into the syringe barrel immediately after use, thereby enhancing safety for healthcare workers and patients.

The company’s flagship product, VanishPoint®, features a one-handed, automatic retraction mechanism and is available in multiple configurations, including standard syringes and Luer-lock fittings.